RA Capital Management buys USD 456,297 of Artiva Biotherapeutics common shares
ARTV•RA Capital Management reported open-market purchases
- RA Capital Management reported open-market purchases of Artiva Biotherapeutics common stock at USD 9.93–9.99 a share.
- Beneficial ownership rose to 17,329,570 shares held indirectly.
